CEREBRUM Trademark

Trademark Overview

On Tuesday, February 7, 2023, a trademark application was filed for CEREBRUM with the United States Patent and Trademark Office. The USPTO has given the CEREBRUM trademark a serial number of 97784494. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, March 18, 2025. This trademark is owned by Praxis Precision Medicines, Inc.. The CEREBRUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological disorders and central nervous system disorders
cerebrum

General Information

Serial Number97784494
Word MarkCEREBRUM
Filing DateTuesday, February 7, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, March 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological disorders and central nervous system disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePraxis Precision Medicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02110
Party NamePraxis Precision Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02110

Trademark Events

Event DateEvent Description
Friday, February 10, 2023NEW APPLICATION ENTERED
Monday, February 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 5, 2023ASSIGNED TO EXAMINER
Thursday, September 7, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, September 7, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, September 7, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 7, 2023EXAMINER'S AMENDMENT ENTERED
Friday, September 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, November 13, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, February 28, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, April 2, 2024ASSIGNED TO PETITION STAFF
Friday, April 5, 2024POST PUBLICATION AMENDMENT - ENTERED
Thursday, April 25, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 27, 2024SOU EXTENSION 1 FILED
Wednesday, November 27, 2024DIVISIONAL REQUEST RECEIVED
Wednesday, November 27, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, November 27, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, February 11, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 19, 2025DIVISIONAL PROCESSING COMPLETE
Tuesday, March 18, 2025SOU EXTENSION 1 GRANTED
Tuesday, March 18, 2025CORRECTED NOA E-MAILED
Wednesday, March 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

cerebrum disorders central system nervous neurological preparations treatment pharmaceutical